Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Salituro

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Journal of Neuroscience Research|August 27, 2015
Rescue of deficient amygdala tonic γ-aminobutyric acidergic currents in the Fmr-/y mouse model of fragile X syndrome by a novel γ-aminobutyric acid type A receptor-positive allosteric modulatorBrandon S Martin, Gabriel Martinez-Botella, Carlos M Loya, et al.
Molecular Pharmacology|October 1, 1990
Activity of 5,7-dichlorokynurenic acid, a potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding siteB M Baron, B L Harrison, F P Miller, et al.
Bioorganic & Medicinal Chemistry Letters|December 1, 2009
A novel chemotype of kinase inhibitors: Discovery of 3,4-ring fused 7-azaindoles and deazapurines as potent JAK2 inhibitorsTiansheng Wang, Mark W Ledeboer, John P Duffy, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
Novel inhibitors of HIV protease: design, synthesis and biological evaluation of picomolar inhibitors containing cyclic P1/P2 scaffoldsA Spaltenstein, M R Almond, W J Bock, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1992
Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding siteB M Baron, B L Harrison, I A McDonald, et al.
European Journal of Pharmacology|September 15, 1995
MDL 100,458 and MDL 102,288: two potent and selective glycine receptor antagonists with different functional profilesJ H Kehne, B M Baron, B L Harrison, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 1999
Design, synthesis, and conformational analysis of a novel series of HIV protease inhibitorsC T Baker, F G Salituro, J J Court, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2008
Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK)Luc J Farmer, Guy Bemis, Shawn D Britt, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 1999
Design and synthesis of novel conformationally restricted HIV protease inhibitorsF G Salituro, C T Baker, J J Court, et al.
European Journal of Pharmacology|April 4, 1997
Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonistB M Baron, B L Harrison, J H Kehne, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Journal of Neuroscience Research|August 27, 2015
Rescue of deficient amygdala tonic γ-aminobutyric acidergic currents in the Fmr-/y mouse model of fragile X syndrome by a novel γ-aminobutyric acid type A receptor-positive allosteric modulatorBrandon S Martin, Gabriel Martinez-Botella, Carlos M Loya, et al.
Molecular Pharmacology|October 1, 1990
Activity of 5,7-dichlorokynurenic acid, a potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding siteB M Baron, B L Harrison, F P Miller, et al.
Bioorganic & Medicinal Chemistry Letters|December 1, 2009
A novel chemotype of kinase inhibitors: Discovery of 3,4-ring fused 7-azaindoles and deazapurines as potent JAK2 inhibitorsTiansheng Wang, Mark W Ledeboer, John P Duffy, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2000
Novel inhibitors of HIV protease: design, synthesis and biological evaluation of picomolar inhibitors containing cyclic P1/P2 scaffoldsA Spaltenstein, M R Almond, W J Bock, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1992
Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding siteB M Baron, B L Harrison, I A McDonald, et al.
European Journal of Pharmacology|September 15, 1995
MDL 100,458 and MDL 102,288: two potent and selective glycine receptor antagonists with different functional profilesJ H Kehne, B M Baron, B L Harrison, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 1999
Design, synthesis, and conformational analysis of a novel series of HIV protease inhibitorsC T Baker, F G Salituro, J J Court, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2008
Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK)Luc J Farmer, Guy Bemis, Shawn D Britt, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 1999
Design and synthesis of novel conformationally restricted HIV protease inhibitorsF G Salituro, C T Baker, J J Court, et al.
European Journal of Pharmacology|April 4, 1997
Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonistB M Baron, B L Harrison, J H Kehne, et al.
Pageof 5